|
1
|
Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts.
|
Eur J Clin Microbiol Infect Dis
|
2000
|
1.55
|
|
2
|
Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi.
|
Antimicrob Agents Chemother
|
1998
|
1.43
|
|
3
|
Pharmacokinetics-pharmacodynamics of a sordarin derivative (GM 237354) in a murine model of lethal candidiasis.
|
Antimicrob Agents Chemother
|
2000
|
1.17
|
|
4
|
Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.
|
Antimicrob Agents Chemother
|
2001
|
1.11
|
|
5
|
In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent.
|
Antimicrob Agents Chemother
|
1993
|
1.00
|
|
6
|
High seroprevalence of Pneumocystis infection in Spanish children.
|
Clin Microbiol Infect
|
2004
|
0.99
|
|
7
|
In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats.
|
Antimicrob Agents Chemother
|
2000
|
0.97
|
|
8
|
Magnetic resonance imaging in the evaluation of inflammatory lesions in muscular and soft tissues: an experimental infection model induced by Candida albicans.
|
Magn Reson Imaging
|
1999
|
0.95
|
|
9
|
Activities of sordarins in experimental models of candidiasis, aspergillosis, and pneumocystosis.
|
Antimicrob Agents Chemother
|
2000
|
0.95
|
|
10
|
Development of pneumocystosis animal models: corticosteroid-treated Wistar rat; SCID mouse and nude rat.
|
J Eukaryot Microbiol
|
1998
|
0.92
|
|
11
|
Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolones.
|
Antimicrob Agents Chemother
|
1996
|
0.90
|
|
12
|
Microplate assays for in vitro evaluation of anti-Pneumocystis drugs.
|
J Eukaryot Microbiol
|
1998
|
0.89
|
|
13
|
Antifungal activities and cytotoxicity studies of six new azasordarins.
|
Antimicrob Agents Chemother
|
2001
|
0.88
|
|
14
|
Correlation between in vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein binding.
|
Antimicrob Agents Chemother
|
2001
|
0.86
|
|
15
|
Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
|
Antimicrob Agents Chemother
|
2001
|
0.85
|
|
16
|
E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens.
|
Antimicrob Agents Chemother
|
1995
|
0.82
|
|
17
|
Animal pharmacokinetics and interspecies scaling of sordarin derivatives following intravenous administration.
|
Antimicrob Agents Chemother
|
2001
|
0.77
|
|
18
|
In vitro activity of Ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria.
|
Antimicrob Agents Chemother
|
2013
|
0.75
|